Source: Annual Congress 2012 - Predicting and observing paediatric allergic disease
Disease area: Airway diseases, Paediatric lung diseases

Abstract

Background: Children with sickle cell disease (SCD) have evidence of airflow limitation on spirometry, and evidence for increased airway nitric oxide (NO) levels.
Objective: To determine the relationship between phenotypic characteristics (atopy, asthma, acute chest syndrome (ACS), pulmonary function test abnormalities) and airway NO levels in children with SCD.
Methods: Children with SCD were recruited during visits for routine annual pulmonary function testing. Subjects completed ISAAC/medical questionnaires, skin prick testing for aeroallergen sensitization, and pulmonary function testing. Nasal (NNO) and the fraction of exhaled NO (FENO) were measured. Subjects were classified by phenotypic characteristics, and NNO and FENO compared between groups, using Mann-Whitney tests.
Results: 154 children participated. Seventy-six (49%) were male. Mean(±SD) age was 12.6±3.3 years. Hemoglobin levels were 96.0±18.3 g/L. FVC, FEV₁, and FEF_25-75 were 86.7±14.0, 84.7±15.0, and 84.4±30.0 percent predicted, respectively. NNO and FENO were 890±387 and 17.9±15.9 ppb.
Eighty (52%) subjects were atopic. Thirteen (8%) subjects taking asthma medication, and 38 (25%) with an asthma diagnosis or wheezing, were classified as asthmatic. Twenty (13%) subjects had a significant bronchodilator response (≥12%) in FEV₁ or FVC. Seventy-three (47%) subjects reported previous ACS or pneumonia. No significant differences were seen in NNO or FENO between any groups compared.
Conclusions: Airway NO measurements did not correlate with any of the phenotypic characteristics evaluated in this cohort of children with SCD, and therefore may not be a meaningful tool in the assessment of SCD lung disease.

Rating:

Share or cite this content

Citations should be made in the following way:
G. Bendiak, D. Mateos-Corral, A. Sallam, H. Grasemann (Toronto, Canada). Relationship between phenotypic characteristics of children with sickle cell disease and airway nitric oxide levels. Eur Respir J 2012; 40: Suppl. 56, 1947

Member's Comments

No comment yet.

Related content which might interest you: Exhaled nitric oxide and pulmonary function in children with sickle cell disease Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010 Relationship of exaled nitric oxide and pulmonary function tests in childhood asthma Source: Eur Respir J 2006; 28: Suppl. 50, 679s Year: 2006 Changes in nitric oxide production in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007 Exhaled nitric oxide and blood eosinophilia: biomarkers of different adult asthma phenotypes Source: International Congress 2017 – Monitoring asthma control Year: 2017 Does exhaled nitric oxide and blood eosinophil count correlate in phenotypes of severe and brittle asthma? Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Association between nitric oxide and clinical phenotype in children with CF Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Correlation between exhaled nitric oxide, airway hyper responsiveness and pulmonary function data in patients with suspected asthma Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Relationship of peripheral eosinophil count in patients with asthma to weight, pulmonary function tests, and exhaled nitric oxide. Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Combined effects of type 2 inflammation and lung function on exhaled nitric oxide ability to reflect asthma control Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Changes in nitric oxide production in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 Clinical utility of nitric oxide metabolite level assessment in blood of patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002 Exhaled nitric oxide is better related to bronchial responsiveness and eosinophil activation in children than adults with asthma Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 Predicting asthma in symptomatic preschool children: contribution of exhaled nitric oxide, rint and specific IgE Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis Year: 2009 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008 Increased alveolar and bronchial nitric oxide output in patients with asthmatic symptoms but normal lung function Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002 Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Childhood wheezing phenotypes influence asthma, lung function and exhaled nitric oxide fraction in adolescence Source: Eur Respir J 2016; 47: 510-519 Year: 2016 Clinical correlates of alveolar nitric oxide in COPD Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 In vitro peripheral blood T-cell responses and exhaled nitric oxide measurements in atopic children with and without increased airway responsiveness Source: Eur Respir J 2004; 24: Suppl. 48, 161s Year: 2004